Join A Study
Chronic Kidney Disease (CKD) is a common complication of diabetes. People with diabetes and CKD may have large variation in blood sugar, including very low blood glucose. This may be unhealthy, leading to problems with memory and thinking, heart disease, and infections. The main purpose of this study is to understand how blood sugar varies in people with diabetes and CKD. This knowledge will help improve management of blood glucose. There will be 4 study visits over a 4-week period. Participants will wear a continuous glucose monitor for two-6 day periods. They will also complete questionnaires, undergo a brief physical examination, and give blood and urine samples. Participants will receive a gift card worth $25 for each study visit they complete, as well as a print out of their glucose monitoring results.
We are seeking patients with kidney disease to participate in a University of Washington clinical study to generate stem cells from urine or hair samples. The stem cells will be used to generate new kidney cells for study of kidney disease and regeneration in the laboratory. The study is free and does not involve compensation.
Chronic Kidney Disease (CKD) affects more than 20 million adults in America. CKD may affect the normal functioning of skeletal muscle, leading to fatigue, weakness, and changes to the way the body processes nutrients. The main purpose of this study is to understand how CKD affects muscle mitochondria, an essential component of skeletal muscle cells. We are enrolling 150 people who have CKD and are between the ages of 18-90 years old. Participants will undergo a specialized, non-invasive MRI test on their hand muscle that will measure mitochondrial function. Also, participants will complete health-related questionnaires, undergo a brief physical examination, and provide blood and urine samples.
Preventing Early Renal Loss in Type 1 Diabetes (PERL) Study group is studying a medication called allopurinol to see if it can prevent the loss of kidney function that occurs in about 1 in 5 people with Type 1 diabetes. The study takes place over 3 and half years and involves 14-17 study visits. Participants will take study medication every day and undergo blood testing every 4 months. To reimburse you for your time and effort in taking part in this study, gift cards will be given for participation.